Colorectal cancer therapy market to hold steady at $7.7B

The market for colorectal cancer therapies will hold steady, valued at $7.7 billion by 2023, according to a Decision Resources Group news release.

Advertisement

The report covers the United States, France, Germany, Italy, Spain, Japan and the United Kingdom.

More articles on gastroenterology:
A world without colonoscopy? 9 gastroenterologists weigh in on the future of GI’s top procedure
Are surveillance colonoscopy practices due for an update?
5 things to know about colonoscopy payment: AGA bundle vs. Medicare model

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.